Results 191 to 200 of about 40,027 (305)

Renoprotective Effect of Coix lachryma‐jobi L. Seed Polysaccharides in Adenine‐Induced Chronic Renal Failure by Blocking Gut Urea Metabolism

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
ABSTRACT Dietary soluble fiber may alleviate renal damage in chronic kidney disease (CKD) by promoting intestinal urea excretion, though the underlying mechanisms remain unclear. This study investigated the digestion, fermentation, and renoprotective effects of Coix lachryma‐jobi L.
Hongmei Yin   +9 more
wiley   +1 more source

Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain [PDF]

open access: bronze, 1995
Pari Malherbe   +3 more
openalex   +1 more source

Mitigation of Metabolic Diseases Through Personalized Nutrition: A Critical In‐Depth Review

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
The main objective of this review is to explore the impact of variation within the microbiome and among genes on nutrient metabolism and argue in favor of successful evidence of individualized dietary intervention for cardiovascular disease, diabetes, and obesity.
Muhammad Tayyab Arshad   +7 more
wiley   +1 more source

Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters

open access: gold, 2018
Gayan Jayawickrama   +3 more
openalex   +2 more sources

People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case–control study [PDF]

open access: gold
Miguel A. Frias   +10 more
openalex   +1 more source

Metabolic Profiling of the EmDia Cohort by LC‐MS Reveals Empagliflozin‐Intake Associated Regulation of 1,5‐anhydroglucitol and Urate

open access: yesPROTEOMICS, Volume 26, Issue 1, Page 44-56, January 2026.
ABSTRACT The EmDia trial, designed to study the effects of the sodium glucose cotransporter‐2 (SGLT2) inhibitor empagliflozin on cardiovascular comorbidities in type 2 diabetes mellitus (T2DM) patients, has been investigated for short‐term metabolic alterations by a limited set of clinical assays. To expand on this data, we report on the development of
Fabian Schmitt   +7 more
wiley   +1 more source

The Gut Microbiota–Insulin Resistance Axis: Mechanisms, Clinical Implications, and Therapeutic Potential

open access: yesFASEB BioAdvances, Volume 8, Issue 1, January 2026.
Dysbiosis‐induced alterations in microbial metabolite production promote intestinal barrier disruption and systemic inflammation, driving insulin resistance and metabolic dysfunction. Microbiota‐targeting therapies represent promising approaches to restore host metabolic health.
Mohamad Al Qassab   +10 more
wiley   +1 more source

Not Aging but Calorie Restriction Strongly Affects Protein Oxidation in Heart and Brain Mitochondria

open access: yesAging Cell, Volume 25, Issue 1, January 2026.
Our comprehensive proteomic analysis reveals that calorie restriction (CR), not aging, is the primary driver of mitochondrial protein oxidation, with striking tissue‐specific effects. While CR reduces oxidation in the heart, it exerts a dual and opposing role within the cerebrum. ABSTRACT Aging is an inevitable consequence for all organisms.
Shipan Fan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy